These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11177567)

  • 1. Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
    Guidance for Industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER).
    Hum Gene Ther; 2001 Feb; 12(3):315-20. PubMed ID: 11177567
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells.
    Long Z; Li LP; Grooms T; Lockey C; Nader K; Mychkovsky I; Mueller S; Burimski I; Ryan P; Kikuchi G; Ennist D; Marcus S; Otto E; McGarrity G
    Hum Gene Ther; 1998 May; 9(8):1165-72. PubMed ID: 9625255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
    Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
    J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.
    Marcucci KT; Jadlowsky JK; Hwang WT; Suhoski-Davis M; Gonzalez VE; Kulikovskaya I; Gupta M; Lacey SF; Plesa G; Chew A; Melenhorst JJ; Levine BL; June CH
    Mol Ther; 2018 Jan; 26(1):269-279. PubMed ID: 29203150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors.
    Wilson CA; Ng TH; Miller AE
    Hum Gene Ther; 1997 May; 8(7):869-74. PubMed ID: 9143913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirus molecular conjugates.
    Zhong Q; Kolls JK; Schwarzenberger P
    Cell Mol Life Sci; 2002 Dec; 59(12):2083-7. PubMed ID: 12568334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
    Wilson CA; Cichutek K
    Methods Mol Biol; 2009; 506():477-88. PubMed ID: 19110646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vectors for cancer gene therapy.
    Collins M
    Ernst Schering Res Found Workshop; 2000; (30):99-104. PubMed ID: 10943318
    [No Abstract]   [Full Text] [Related]  

  • 9. Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
    Cornetta K; Yao J; House K; Duffy L; Adusumilli PS; Beyer R; Booth C; Brenner M; Curran K; Grilley B; Heslop H; Hinrichs CS; Kaplan RN; Kiem HP; Kochenderfer J; Kohn DB; Mailankody S; Norberg SM; O'Cearbhaill RE; Pappas J; Park J; Ramos C; Ribas A; Rivière I; Rosenberg SA; Sauter C; Shah NN; Slovin SF; Thrasher A; Williams DA; Lin TY
    Mol Ther; 2023 Mar; 31(3):801-809. PubMed ID: 36518078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell line issues related to specific expression vectors: retrovirus vectors.
    Morgan EM
    Dev Biol Stand; 1992; 76():301-5. PubMed ID: 1478348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of replication competent retrovirus and lentivirus.
    Sastry L; Cornetta K
    Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral vectors for gene therapy.
    Maier P; von Kalle C; Laufs S
    Future Microbiol; 2010 Oct; 5(10):1507-23. PubMed ID: 21073311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Points to consider in human somatic cell therapy and gene therapy (1991).
    Hum Gene Ther; 1991; 2(3):251-6. PubMed ID: 1751593
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety considerations in somatic gene therapy of human disease with retrovirus vectors.
    Temin HM
    Hum Gene Ther; 1990; 1(2):111-23. PubMed ID: 2078575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials involving multidrug resistance transcription units in retroviral vectors.
    Deisseroth AB
    Clin Cancer Res; 1999 Jul; 5(7):1607-9. PubMed ID: 10430058
    [No Abstract]   [Full Text] [Related]  

  • 16. Retroviral vectors. From laboratory tools to molecular medicine.
    Vile RG; Tuszynski A; Castleden S
    Mol Biotechnol; 1996 Apr; 5(2):139-58. PubMed ID: 8734426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant human GM-CSF retroviral vector construction and expression in human breast cancer cells].
    Zhao M; Mao N; Ba D
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):42-4. PubMed ID: 10743054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy. What to do when clear success comes with an unclear risk?
    Marshall E
    Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy.
    Long Z; Lu P; Grooms T; Mychkovsky I; Westley T; Fitzgerald T; Sharma-Chibber S; Shand N; McGarrity G; Otto E
    Hum Gene Ther; 1999 Mar; 10(5):733-40. PubMed ID: 10210141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference between effector RNAs expressed from conventional dual-function anti-HIV retroviral vectors can be circumvented using dual-effector-cassette retroviral vectors.
    Peng H; Callison D; Li P; Burrell CJ
    Hum Gene Ther; 1999 Feb; 10(3):449-62. PubMed ID: 10048397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.